Table 2.
Means, SEs, and between-group effect sizes (Cohen d) from baseline to 1-year follow-up.
|
|
Baseline | One-year follow-up | |||
|
|
Transdiagnostic iCBTa, mean (SE) | TAUb, mean (SE) | Transdiagnostic iCBT, mean (SE) | TAU, mean (SE) | Cohen d (95% CI) |
| BDI-IIc | 23.4 (1.4) | 24.1 (1.4) | 13.4 (1.7) | 18.3 (1.6) | 0.43 (0.02 to 0.85) |
| BAId | 20.0 (1.3) | 22.3 (1.2) | 13.1 (1.6) | 16.9 (1.6) | 0.34 (–0.07 to 0.75) |
| EQ-5D-3L | 55.8 (2.0) | 53.5 (1.9) | 69.6 (2.6) | 59.7 (2.5) | –0.57 (–0.98 to –0.15) |
| BISe scale | 23.3 (0.3) | 23.4 (0.3) | 21.2 (0.4) | 23.6 (0.4) | 0.87 (–1.30 to –0.45) |
| BASf scale | 35.3 (0.6) | 35.8 (0.6) | 36.0 (0.8) | 34.8 (0.8) | 0.22 (–0.19 to 0.63) |
aiCBT: internet-delivered cognitive behavioral therapy.
bTAU: treatment as usual.
cBDI-II: Beck Depression Inventory, Second Edition.
dBAI: Beck Anxiety Inventory.
eBIS: behavioral inhibition system.
fBAS: behavioral activation system.